Valeant nears deal to buy Salix for about $10 billion: WSJ

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. REUTERS/Christinne Muschi

(Reuters) - Valeant Pharmaceuticals International is near a deal to buy Salix Pharmaceuticals Ltd for about $10 billion, the Wall Street Journal reported on Saturday. (Reporting by Eric Beech)